Table 2 The relationship between the clinical characteristics and MOR expression level in 180 patients with colorectal cancer
|
Variables |
Score=0/1 ( n=85) |
Score=2/3 ( n=95) |
P value |
|
Age (years) |
|||
|
<60 |
22 (12.2) |
27 (15.0) |
0.702 |
|
≥60 |
63 (35.0) |
68 (37.8) |
|
|
Gender |
|
||
|
Male |
42 (23.3) |
57 (31.7) |
0.154 |
|
Female |
43 (23.9) |
38 (21.1) |
|
|
Stage |
|
||
|
I–II |
55 (30.6) |
49 (27.2) |
0.075 |
|
III–IV |
30 (16.7) |
46 (25.7) |
|
|
Tumor size (cm) |
|
|
|
|
<3 |
5 (2.80) |
5 (2.80) |
0.382 |
|
3–5 |
33 (18.3) |
28 (15.6) |
|
|
>5 |
47 (26.1) |
62 (34.4) |
|
|
Gross appearance |
|||
|
Exophytic |
30 (16.7) |
25 (13.9) |
0.076 |
|
Ulcerative |
5 (2.80) |
15 (8.30) |
|
|
Infiltration |
50 (27.8) |
55 (30.5) |
|
|
Histological type |
|||
|
Adenocarcinoma |
75 (41.7) |
83 (46.1) |
0.859 |
|
Mucinous adenocarcinoma |
10 (5.60) |
12 (6.60) |
|
|
Tumor differentiation |
78 (43.3) |
63 (35.0) |
<0.001 |
|
I–II (Well) |
7 (3.9) |
32 (17.8) |
|
|
III–IV (Poor) |
|||
|
Depth of invasion |
|||
|
T1–T2 |
6 (3.30) |
9 (5.00) |
|
|
T3–T4 |
79 (43.9) |
86 (47.8) |
0.558 |
|
Lymph node metastasis |
|||
|
T0 |
60 (33.3) |
46 (25.6) |
<0.001 |
|
T1 |
23 (12.7) |
30 (16.7) |
|
|
T2 |
2 (1.10) |
19 (10.6) |
|
|
Metastasis |
|||
|
Negative |
80 (44.4) |
86 (47.8) |
0.369 |
|
Positive |
5 (2.80) |
9 (5.00) |